Can Glaucoma Be Treated With CBD And THC When They Are Included In CBD?

Glaucoma

According to research, glaucoma is one of the most common eye ailments on a global scale with statistics showing that approximately 60 million individuals go through the status in their own lives. The USA presents with a statistic of more than three million people living with glaucoma and when this really is untreated it can result in irreversible blindness cbd glaucoma.
Since 1980, surgical procedures and treatments have significantly improved the numbers of cancer patients. The procedures have successfully handled the optical neural damage brought on by glaucoma and the probability of developing blindness was reduced by approximately 50%. Nonetheless, while progressing therapies have reduced the probability of blindness in glaucoma patients, the number of effective topical medication has been limited. As such, medical marijuana has been stated as a successful remedy with several people choosing this alternative – but if they be doing this?
Due to this improvement of cancer treatments within the last few years, an individual has to question whether or not the advantages of medical marijuana outweigh the possible risks or side effects? What’s more, the role of the body’s endocannabinoid system in disease should be considered when determining if growth of cannabinoid-based medications are beneficial for treating this condition.

The precise reason for the eye condition, however, has been a puzzle and elude the health community.
Due to intraocular pressure influencing the onset and progression of glaucoma, ophthalmologists have started to prescribe treatments that target this intraocular pressure, shortened to IOP. Evidence has demonstrated that the sole method of preventing irreversible blindness or vision loss is the decrease of IOP levels utilizing different therapies. The type of treatment selected is typically dependent on the seriousness and the progression of the eye conditionnonetheless, ophthalmologists will more often not to treat glaucoma with prescription drugs. A severe case would potentially require operation.

Studies from the 1970s indicate that cannabinoids present with properties that could reduce glaucoma-related symptoms because of their capability for lowering the IOP degrees in the patient. What’s more, the cannabinoids introduced with neuroprotective actions. In 1971, the initial study of CBD as therapy for glaucoma discovered that ingestion of this substance decreased the patient’s IOP levels by 25-30 percent.
Regardless of the medical findings from the research by the 1970s, it’s uncommon that an ophthalmologist will use medical marijuana in patients experiencing premature to mid-stage glaucoma. The principal problem many ophthalmologists have with the usage of medical CBD is the potential side effects and how smoking CBD can outweigh the short term benefits of this treatment. For example, smoking CBD could lead to unstable intraocular pressure amounts, thus increasing the chance of irreversible blindness from the patient.
Another point of concern that many ophthalmologists have is that the therapeutic effects of medical marijuana are short term for glaucoma sufferers; hence, the individual would need to consume CBD on a normal basis – potentially every three or four hours. Medical practitioners have promised that glaucoma requires therapy 24 hours every day and patients would need to eat medical CBD about six to eight times in 1 day to be suitably treated for their condition. A frequency in this level can be difficult to maintain and, on account of the total amount of intake, can increase the risk of developing a CBD dependence.
When the patient is experiencing a late stage glaucoma condition, it’s frequently seen that ophthalmologists are more likely to opt for medical marijuana as a form of therapy. This is because of the fact that treatment at the late phase of glaucoma concentrates more on relieving the related symptoms of the condition rather than targeting the illness itself. According to Andrew Bainnson, the medical community has been aware of the effectiveness of medical marijuana in treating pain and nausea; nonetheless, not glaucoma. Of course, there are individuals at the end phase of nausea and pain which may benefit from this therapy but not in the view of glaucoma.
• Are CBD-Based Remedies Beneficial As Future Glaucoma Treatments?
Among the most critical physiological methods in the human body is its inner cannabinoid system, also known as the endocannabinoid system. Virtually all facets of the human body’s health, including immune system response, inflammation, pain modulation and neuroprotection are dependent on the skills of the endocannabinoid system. Therefore, many medical researchers believe that the development and application of cannabinoid-based treatments can be highly valuable in treatment and possibly preventing conditions such as glaucoma.
The cannabinoid receptors within the human anatomy are notable in ocular cells responsible for the regulation of intraocular pressure. Future medical research is currently working towards the growth of cannabinoid-based drugs to target these problems. This type of medication will be highly beneficial in that it will treat two separate issues: lowering the intraocular pressure and security of retinal cells.
Current research has discovered that two cannabinoid agonists (WIN 55212-2 and anandamid) along with several other cannabinoids, such as CBG and CBD, may be useful when developing therapies for glaucoma. This is very true in the case of drugs that are administered directly to the patient’s attention because they are well-tolerated by the human body.
Unfortunately, problems which aren’t specific to medical marijuana are still exist. An oral preparation and application of CBD isn’t beneficial because the bioavailability is poor with absorption being inconsistent. Furthermore, inhalation of CBD isn’t successful as the consequences are not long-lasting.

Leave a Reply

Your email address will not be published. Required fields are marked *